ANALYN TESORO-OFIARA: Open Payments
NPI 1225529761 · ATLANTIC BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,450 in 83 payments from 19 companies in 2025. Trend: 2023 $1,032 · 2024 $2,361 · 2025 $2,450
Food & beverage: $2,450
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $554 |
| ABBVIE INC. | 13 | $459 |
| Daiichi Sankyo Inc. | 6 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $236 |
| Novo Nordisk Inc | 11 | $207 |
| Amgen Inc. | 8 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $136 |
| Exact Sciences Corporation | 4 | $73 |
| PFIZER INC. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
Products named: AIRSUPRA, INJECTAFER, VRAYLAR, UBRELVY, BREZTRI, FARXIGA, QULIPTA, Lynkuet.
Industry payments across FL — which companies pay providers there.
